Rituxan Genentech (Health/Medications)
non-hodgkins-lymphoma.rituxan.com

Description: Information about NonHodgkins Lymphoma and Rituxan (Rituximab), the first U.S. approved monoclonal antibody cancer treatment to treat NonHodgkins Lymphoma. Rituxan (Rituximab) is the first monoclonal antibody cancer therapy approved in the United States. Healthcare professionals can find clinical trial, dosage and administration, and patient reimbursement information (SPOC). Presented by Genentech, Inc, and Idec Pharmaceuticals, Inc

Specializes in: nonhodgkins lymphoma cancer treatment non hodgkins bcell rituxan rituximab monoclonal

Website owner:

No match for NON-HODGKINS-LYMPHOMA.RITUXAN.COM.